Top Markets
#1 Black Phoenix Black Phoenix +354.83%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +76.50%
#4 Gold Park Gold Park +60.52%
#5 Acurast Acurast +38.24%
#6 OpenEden OpenEden +36.58%
#7 BasedHype BasedHype +27.21%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +20.59%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +20.03%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation

GSTC
Rangering i aksjer #40541
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm... GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-12
Markedsverdi
$124.11K
Endring (1 dag)
0.00%
Endring (1 år)
9,900.00%
Land
US
Handel GlobeStar Therapeutics Corporation (GSTC)

Kategori

Healthcare
Inntekter for GlobeStar Therapeutics Corporation (GSTC)
Inntekter i 2026 TTM: 0
Ifølge GlobeStar Therapeutics Corporation sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for GlobeStar Therapeutics Corporation fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE